» Articles » PMID: 4988783

Radioimmunoassay of Human Plasma Retinol-binding Protein

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1970 Sep 1
PMID 4988783
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A radioimmunoassay for human plasma retinol-binding protein (RBP) has been developed utilizing a double antibody precipitation technique. RBP was purified 1500- to 2000-fold by procedures described previously. A specific anti-human RBP antiserum was prepared in rabbits by three once-weekly injections of purified RBP emulsified with Freund's adjuvant. RBP was iodinated with (131)I and the RBP-(131)I was purified by gel filtration on Sephadex G-100 after complex formation with human plasma prealbumin. The RBP-(131)I was completely (> 95%) immunoprecipitable in the presence of an excess of specific antiserum, it was not (< 5%) immunoprecipitable in the absence of specific antiserum, and it could be completely displaced from antibody by excess unlabeled RBP. The standard curve obtained in the immunoassay with normal plasma was identical to that with pure RBP. Duplicate samples differed from their mean by 5 +/-5% (+/-SD). There was a quantitative recovery of pure RBP added in varying amounts to normal plasma. The immunoassay accurately measured RBP in amounts of 10-100 ng per assay tube. There was no significant difference in the immunoreactivity of apo-RBP as compared to holo-RBP. The mean plasma values (+/-SEM) for a group of 76 normal subjects were 47.2 +/-1.6 mug/ml for males and 41.6 +/-1.6 mug/ml for females. Plasma RBP levels were markedly depressed (15 +/-2.3 mug/ml) in 14 patients with acute viral hepatitis. There was a highly significant correlation between the plasma levels of RBP and of vitamin A in both normal subjects and patients with hepatitis. In all subjects plasma RBP was generally saturated with retinol. The data suggest that under normal circumstances RBP circulates almost exclusively as the holoprotein.

Citing Articles

Are we creating a new phenotype? Physiological barriers and ethical considerations in the treatment of hereditary transthyretin-amyloidosis.

Dohrn M, Medina J, Olaciregui Dague K, Hund E Neurol Res Pract. 2021; 3(1):57.

PMID: 34719408 PMC: 8559355. DOI: 10.1186/s42466-021-00155-8.


A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.

Ernoult E, Bourreau A, Gamelin E, Guette C J Biomed Biotechnol. 2009; 2010:927917.

PMID: 19888438 PMC: 2771280. DOI: 10.1155/2010/927917.


The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma.

Smith F, Goodman D J Clin Invest. 1971; 50(11):2426-36.

PMID: 5096525 PMC: 292185. DOI: 10.1172/JCI106741.


Retinol transport in rat plasma and its nutritional regulation.

Goodman D, Muto Y, Smith J, Milch P Biochem J. 1972; 128(1):15P.

PMID: 5085553 PMC: 1173612. DOI: 10.1042/bj1280015p.


The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma.

Smith J, Goodman D J Clin Invest. 1971; 50(10):2159-67.

PMID: 4330006 PMC: 292150. DOI: 10.1172/JCI106710.


References
1.
Kanai M, Raz A, Goodman D . Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest. 1968; 47(9):2025-44. PMC: 297364. DOI: 10.1172/JCI105889. View

2.
Raz A, Goodman D . The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem. 1969; 244(12):3230-7. View

3.
Goodman D . Retinol transport in human plasma. Am J Clin Nutr. 1969; 22(7):911-2. DOI: 10.1093/ajcn/22.7.911. View

4.
Raz A, Shiratori T, Goodman D . Studies on the protein-protein and protein-ligand interactions involved in retinol transport in plasma. J Biol Chem. 1970; 245(8):1903-12. View

5.
Grabar P, WILLIAMS Jr C . [Immunoelectrophoretic method for the analysis of mixtures of antigenic substances]. Biochim Biophys Acta. 1955; 17(1):67-74. DOI: 10.1016/0006-3002(55)90320-6. View